BELL vs. POLX, AVO, RUA, SUN, MHC, MXCT, DEMG, SN, NIOX, and EKF
Should you be buying Belluscura stock or one of its competitors? The main competitors of Belluscura include Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), MaxCyte (MXCT), Deltex Medical Group (DEMG), Smith & Nephew (SN), NIOX Group (NIOX), and EKF Diagnostics (EKF). These companies are all part of the "medical devices" industry.
Belluscura vs. Its Competitors
Polarean Imaging (LON:POLX) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.
Belluscura has a net margin of -1,030.73% compared to Polarean Imaging's net margin of -1,333.97%. Polarean Imaging's return on equity of -86.11% beat Belluscura's return on equity.
10.2% of Polarean Imaging shares are owned by institutional investors. Comparatively, 4.0% of Belluscura shares are owned by institutional investors. 3.5% of Polarean Imaging shares are owned by insiders. Comparatively, 7.1% of Belluscura shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Belluscura has lower revenue, but higher earnings than Polarean Imaging. Polarean Imaging is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks.
In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled Belluscura'saverage media sentiment score.
Polarean Imaging has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, Belluscura has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.
Summary
Polarean Imaging beats Belluscura on 6 of the 11 factors compared between the two stocks.
Get Belluscura News Delivered to You Automatically
Sign up to receive the latest news and ratings for BELL and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Belluscura Competitors List
Related Companies and Tools
This page (LON:BELL) was last updated on 9/13/2025 by MarketBeat.com Staff
